Explore the Future

Today, we are living through a time of great change, which is evident in the three domains of Energy & Environment, Bio & Healthcare, and Materials & Semiconductors. HORIBA is bringing together its five business segments in diverse combinations to be able to provide analytical and measurement technologies for these three megatrends. Innovations in these domains are essential for creating a sustainable society where public safety and security are ensured.

HORIBA has more than 30+ years of experience in the healthcare industry. HORIBA has reached international reputation thanks to its high standards in terms of innovation. With its flexible production units and pioneering R&D centers, it is always a step ahead in developing products, always responding to market needs. HORIBA develops solutions which are adapted to its customers’ demands and anticipates their needs thanks to technological creativity. Drawing on its extensive experience and its strong reputation in hematology & has become a major player in the IVD industry.

HORIBA is engaged in a long-term mission to provide laboratories with innovative products and services that exceed their expectations. Being the preferred partner in healthcare diagnostic solutions is not only HORIBA’s vision but it also guides our daily decisions and choices. Quality is not just an assurance but HORIBA’s long-term commitment to its worldwide users. HORIBA has clearly integrated this value on a continuous investment in product development, innovation, and sustaining programs.

In recent years, we have expanded into the field of Life Science by uniting with scientific analysis equipment technology.

Nowadays, the evolution of information technology is proceeding at a rapid pace; many useful tools, such as electronic medical records have been installed in various clinical sites. The need for clinical test devices to be connected to networks is also increasing. To meet this requirement, HORIBA did not just incorporate a simple data connection, but began to develop a better system for clinical test devices to give users and patients peace of mind. In the future, HORIBA aims to continuously develop stable, high-accuracy medical devices, and to develop high-accuracy, high-quality clinical systems supported by information technology.

Our marketing strategy for the upcoming year is to enhance customer delight by disseminating scientific knowledge through various programs while focusing on product diversification. We are continuously working toward expanding our product portfolio and very soon will be coming up with multiple new products.

In the year 2024, we will be focusing more on bringing products of indigenous make to customers while ensuring global product standards and quality.

HORIBA has invested in two manufacturing facilities in India for the diagnostics division and these investments contribute to the Make in India of the Government of India’s (GOI) push toward industrial development, economic growth, more job creation, and self-sustainability Atmanirbhar Bharat.

The first facility was set up at Haridwar, which is dedicated to the production of an indigenous range of open-market chemistry reagents Yumizen CR, which are highly cost-effective and high-quality reagents catering to the needs of different laboratories across India.

The second facility is at Nagpur which is spread across an area of 12 acres. This facility comprises of manufacturing, refurbishment, a central warehouse facility, an International Training Center, HORIBA Experience Zone and HORIBA India Technical Institute (HITI). It is one-of-its-kind and is accredited with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 13485:2016 and CE certification.

HORIBA India recently started instrument manufacturing at its state-of-the-art facility at Nagpur with Yumizen CA40, a semi-automated clinical chemistry analyzer with the facility to perform Chemistry, Immunoturbidimetry and Coagulation Tests (PT & APTT). It is an asset for any laboratory, offering several benefits that can help to improve the efficiency, accuracy, and affordability of healthcare. It is ideal for small and mid-sized laboratories and can also work as backup chemistry support for all laboratories with high workloads.

We are also bringing a new benchtop automated Clinical chemistry analyzer Yumizen C150 which has a throughput of 200 tests per hour. It has a unique compact design with inbuilt laundry and cooling facilities for reagents, making it ideal for space-constrained laboratories along with unique software features, such as user-defined reflex action and unlimited patient result storage capacity. This system would be ideal for small and mid-sized laboratories.

Another upcoming system is an Electrolyte analyzer Yumizen E60, which is a user friendly and reliable electrolyte analyzer, ideal for medium to high volume laboratories and hospitals. It allows measurement of specific ions, accurately and precisely, supporting fast diagnosis. It has a throughput of 60 samples per hour, a 5” color LCD touchscreen display and a storage capacity of 10,000 patient results.

We envision starting indigenous manufacturing of hematology analyzers as well at our local manufacturing sites in India.